Nuveen Asset Management, LLC Tenaya Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 286,805 shares of TNYA stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286,805
Previous 156,836
82.87%
Holding current value
$1.21 Million
Previous $508,000
195.08%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$39.6 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$28.3 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$19.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.35MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$12.1 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $174M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...